Optical Tomography (OT) and MR combination for dual-modality imaging
Optical techniques, such as bioluminescence and fluorescence, are emerging as powerful new modalities for molecular imaging in disease and therapy. Combining innovative molecular biology and chemistry, researchers have developed optical methods for imaging a variety of cellular and molecular processes in vivo, including protein interactions, protein degradation, and protease activity.
DKFZ developed an optical imaging detector regarding fluorescence and bioluminescence for small animal imaging, which is compatible for magnetic resonance imaging (MRI). This technology provides the possibility to study simultaneously tracer/marker kinetics of optical (OT) as well as NMR induced signals.
Further Information: PDF
Deutsches Krebsforschungszentrum DKFZ
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Decoding Cancer: 40 Years of Breakthroughs in Genetic Research
Cancer in children and adolescents is rare. Nevertheless, malignant diseases are still one of the most common causes of death in this age group. Survivors of childhood or adolescent cancer…
Let’s Think Before the First Drink: How Early Substance Use Might Lead to Brain Structure Differences Among Adolescents
Many differences appeared to exist prior to any substance use, pointing to the role brain structure may play in substance use risk, NIH-supported study suggests. Studies reveal factors that expose…
Combating Kidney Cancer Using Enhanced Immunotherapies
Medical University of South Carolina Hollings Cancer Center researcher receives Department of Defense Early Career Scholar Award to improve immune therapies by targeting resistant kidney tumors. A Medical University of…